Current patient management of chronic myeloid leukemia in Latin America
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25273/fullpdf
Reference7 articles.
1. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet;Baccarani;Blood.,2006
2. The development of imatinib as a therapeutic agent for chronic myeloid leukemia;Deininger;Blood.,2005
3. Diagnosis and management of chronic myeloid leukemia: a survey of American and European practice patterns;Kantarjian;Cancer.,2007
4. Therapeutic choices in patients with Ph1 (+) chronic myelogenous leukemia living in Mexico in the tyrosine kinase inhibitors (TKI) era: stem cell transplantation or TKI's?;Ruiz-Arguelles;Bone Marrow Transplant.,2008
5. Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R);Kantarjian;Cancer.,2009
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Polymorphisms in Drug Transporter and Metabolism Genes Associated with Resistance to Imatinib in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis;Scientia Pharmaceutica;2023-12-25
2. Challenges in Chronic Myeloid Leukemia Management in South America;Current Hematologic Malignancy Reports;2021-10
3. The blue palate—A case series of imatinib-related oral pigmentation and literature review;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2021-01
4. Treatment patterns and deep molecular response in chronic phase – chronic myeloid leukemia patients treated with second-line nilotinib or dasatinib: a multi-country retrospective chart review study;Leukemia & Lymphoma;2019-08-13
5. Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute – Mexico, from 2000 to 2016;Cancer Medicine;2019-05-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3